NRx Pharmaceuticals receives FDA fast track status for suicide treatment
Tweet Send to a Friend
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) announced the U.S. Food and Drug Administration granted Fast Track Designation for NRX-100 in treating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
